| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of chromatin | H2AB1 H2AB2 H2BC11 H2BC18 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BK1 H2BC5 H2BC3 H2BC12 | 3.66e-20 | 100 | 123 | 17 | GO:0030527 |
| GeneOntologyMolecularFunction | structural molecule activity | SEH1L H2AB1 H2AB2 H2BC11 COL6A3 PNN DSP MRPL27 DAG1 H2BC18 ADD3 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BK1 H2BC5 H2BC3 MYOM2 RIMS1 H2BC12 | 2.72e-11 | 891 | 123 | 26 | GO:0005198 |
| GeneOntologyMolecularFunction | protein heterodimerization activity | H2AB1 H2AB2 H2BC11 H2BC18 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BK1 H2BC5 H2BC3 TAF4 H2BC12 | 4.36e-11 | 398 | 123 | 18 | GO:0046982 |
| GeneOntologyMolecularFunction | protein dimerization activity | H2AB1 H2AB2 H2BC11 ANO2 SMCHD1 TSC2 H2BC18 H2BC12L H2BC1 FICD H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BK1 H2BC5 H2BC3 TAF4 H2BC12 | 4.02e-06 | 1205 | 123 | 22 | GO:0046983 |
| GeneOntologyBiologicalProcess | nucleosome assembly | H2AB1 H2AB2 H2BC11 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC3 KAT6B SPTY2D1 | 1.05e-14 | 122 | 119 | 14 | GO:0006334 |
| GeneOntologyBiologicalProcess | nucleosome organization | H2AB1 H2AB2 H2BC11 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC3 KAT6B SPTY2D1 | 8.93e-14 | 142 | 119 | 14 | GO:0034728 |
| GeneOntologyBiologicalProcess | protein-DNA complex assembly | H2AB1 H2AB2 H2BC11 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC3 TAF4 KAT6B SPTY2D1 | 1.50e-11 | 249 | 119 | 15 | GO:0065004 |
| GeneOntologyBiologicalProcess | innate immune response in mucosa | 1.72e-08 | 30 | 119 | 6 | GO:0002227 | |
| GeneOntologyBiologicalProcess | mucosal immune response | 3.27e-07 | 48 | 119 | 6 | GO:0002385 | |
| GeneOntologyBiologicalProcess | organ or tissue specific immune response | 6.69e-07 | 54 | 119 | 6 | GO:0002251 | |
| GeneOntologyBiologicalProcess | defense response to Gram-positive bacterium | 2.57e-06 | 150 | 119 | 8 | GO:0050830 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | H2AB1 H2AB2 H2BC11 SMCHD1 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC3 KAT6B SPTY2D1 RAD54L | 5.61e-06 | 741 | 119 | 16 | GO:0006338 |
| GeneOntologyBiologicalProcess | antibacterial humoral response | 9.80e-06 | 85 | 119 | 6 | GO:0019731 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 1.31e-05 | 187 | 119 | 8 | GO:0007156 | |
| GeneOntologyBiologicalProcess | chromatin organization | H2AB1 H2AB2 H2BC11 SMCHD1 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 MKI67 H2BC3 KAT6B SPTY2D1 RAD54L | 1.52e-05 | 896 | 119 | 17 | GO:0006325 |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | H2AB1 H2AB2 H2BC11 SMCHD1 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 MKI67 H2BC3 TAF4 KAT6B SPTY2D1 RAD54L | 1.67e-05 | 999 | 119 | 18 | GO:0071824 |
| GeneOntologyBiologicalProcess | regulation of cell-substrate adhesion | 1.68e-05 | 254 | 119 | 9 | GO:0010810 | |
| GeneOntologyBiologicalProcess | embryonic body morphogenesis | 8.10e-05 | 15 | 119 | 3 | GO:0010172 | |
| GeneOntologyBiologicalProcess | positive regulation of excitatory postsynaptic potential | 1.09e-04 | 43 | 119 | 4 | GO:2000463 | |
| GeneOntologyBiologicalProcess | antimicrobial humoral immune response mediated by antimicrobial peptide | 1.28e-04 | 134 | 119 | 6 | GO:0061844 | |
| GeneOntologyBiologicalProcess | positive regulation of cell-substrate adhesion | 2.28e-04 | 149 | 119 | 6 | GO:0010811 | |
| GeneOntologyBiologicalProcess | positive regulation of basement membrane assembly involved in embryonic body morphogenesis | 3.26e-04 | 5 | 119 | 2 | GO:1904261 | |
| GeneOntologyBiologicalProcess | regulation of basement membrane assembly involved in embryonic body morphogenesis | 3.26e-04 | 5 | 119 | 2 | GO:1904259 | |
| GeneOntologyBiologicalProcess | basement membrane assembly involved in embryonic body morphogenesis | 3.26e-04 | 5 | 119 | 2 | GO:2001197 | |
| GeneOntologyCellularComponent | nucleosome | H2AB1 H2AB2 H2BC11 H2BC18 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BK1 H2BC5 H2BC3 KAT6B H2BC12 | 1.77e-19 | 138 | 123 | 18 | GO:0000786 |
| GeneOntologyCellularComponent | chromatin | H2AB1 H2AB2 H2BC11 VAX1 H2BC18 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BK1 H2BC5 H2BC3 ELF2 TAF4 KAT6B H2BC12 | 1.42e-04 | 1480 | 123 | 21 | GO:0000785 |
| Domain | H2B | H2BC11 H2BC18 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.83e-24 | 21 | 119 | 13 | SM00427 |
| Domain | HISTONE_H2B | H2BC11 H2BC18 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.83e-24 | 21 | 119 | 13 | PS00357 |
| Domain | Histone_H2B | H2BC11 H2BC18 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.83e-24 | 21 | 119 | 13 | IPR000558 |
| Domain | Histone | H2AB1 H2AB2 H2BC11 H2BC18 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 6.08e-21 | 56 | 119 | 15 | PF00125 |
| Domain | Histone_H2A/H2B/H3 | H2AB1 H2AB2 H2BC11 H2BC18 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 6.08e-21 | 56 | 119 | 15 | IPR007125 |
| Domain | Histone-fold | H2AB1 H2AB2 H2BC11 H2BC18 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 TAF4 H2BC12 | 9.42e-20 | 83 | 119 | 16 | IPR009072 |
| Domain | - | H2AB1 H2AB2 H2BC11 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 TAF4 H2BC12 | 1.98e-19 | 69 | 119 | 15 | 1.10.20.10 |
| Domain | Cadherin-like | 9.38e-06 | 116 | 119 | 7 | IPR015919 | |
| Domain | - | 4.03e-05 | 2 | 119 | 2 | 2.60.40.1030 | |
| Domain | AP2_complex_asu | 4.03e-05 | 2 | 119 | 2 | IPR017104 | |
| Domain | Clathrin_a-adaptin_app_sub_C | 4.03e-05 | 2 | 119 | 2 | IPR003164 | |
| Domain | Clathrin_a-adaptin_app_Ig-like | 4.03e-05 | 2 | 119 | 2 | IPR013038 | |
| Domain | Alpha_adaptin_C | 4.03e-05 | 2 | 119 | 2 | PF02296 | |
| Domain | Cadherin_CS | 6.99e-05 | 109 | 119 | 6 | IPR020894 | |
| Domain | CADHERIN_1 | 8.55e-05 | 113 | 119 | 6 | PS00232 | |
| Domain | Cadherin | 8.55e-05 | 113 | 119 | 6 | PF00028 | |
| Domain | CADHERIN_2 | 8.98e-05 | 114 | 119 | 6 | PS50268 | |
| Domain | - | 8.98e-05 | 114 | 119 | 6 | 2.60.40.60 | |
| Domain | CA | 9.42e-05 | 115 | 119 | 6 | SM00112 | |
| Domain | Cadherin | 1.09e-04 | 118 | 119 | 6 | IPR002126 | |
| Domain | - | 2.40e-04 | 4 | 119 | 2 | 3.30.310.30 | |
| Domain | Clathrin_a/coatomer_app_sub_C | 2.40e-04 | 4 | 119 | 2 | IPR015873 | |
| Domain | - | ILDR2 NDNF SEMA4D COL6A3 MYCBP2 DAG1 IGSF11 NPTN FNDC7 FCRL3 EPHA2 FCRLB MYOM2 | 3.12e-04 | 663 | 119 | 13 | 2.60.40.10 |
| Domain | Ig-like_fold | ILDR2 NDNF SEMA4D COL6A3 MYCBP2 DAG1 IGSF11 NPTN FNDC7 FCRL3 EPHA2 FCRLB MYOM2 | 5.66e-04 | 706 | 119 | 13 | IPR013783 |
| Domain | Coatomer/calthrin_app_sub_C | 1.10e-03 | 8 | 119 | 2 | IPR009028 | |
| Domain | MCM_OB | 1.10e-03 | 8 | 119 | 2 | IPR033762 | |
| Domain | MCM_2 | 1.10e-03 | 8 | 119 | 2 | PS50051 | |
| Domain | MCM_1 | 1.10e-03 | 8 | 119 | 2 | PS00847 | |
| Domain | MCM_OB | 1.10e-03 | 8 | 119 | 2 | PF17207 | |
| Domain | MCM | 1.41e-03 | 9 | 119 | 2 | SM00350 | |
| Domain | LBP_BPI_CETP | 1.41e-03 | 9 | 119 | 2 | PS00400 | |
| Domain | MCM_dom | 1.41e-03 | 9 | 119 | 2 | IPR001208 | |
| Domain | BPI2 | 1.41e-03 | 9 | 119 | 2 | SM00329 | |
| Domain | Clathrin_a/b/g-adaptin_app_Ig | 1.41e-03 | 9 | 119 | 2 | IPR008152 | |
| Domain | Alpha_adaptinC2 | 1.41e-03 | 9 | 119 | 2 | PF02883 | |
| Domain | MCM | 1.41e-03 | 9 | 119 | 2 | IPR031327 | |
| Domain | Alpha_adaptinC2 | 1.41e-03 | 9 | 119 | 2 | SM00809 | |
| Domain | MCM | 1.41e-03 | 9 | 119 | 2 | PF00493 | |
| Domain | ARM-type_fold | 1.48e-03 | 339 | 119 | 8 | IPR016024 | |
| Domain | LBP_BPI_CETP_C | 1.75e-03 | 10 | 119 | 2 | PF02886 | |
| Domain | Coatomer/clathrin_app_Ig-like | 2.55e-03 | 12 | 119 | 2 | IPR013041 | |
| Domain | Lipid-bd_serum_glycop_C | 2.55e-03 | 12 | 119 | 2 | IPR001124 | |
| Domain | LBP_BPI_CETP | 3.00e-03 | 13 | 119 | 2 | PF01273 | |
| Domain | BPI/LBP/Plunc | 3.00e-03 | 13 | 119 | 2 | IPR032942 | |
| Domain | Bactericidal_perm-incr_a/b_dom | 3.00e-03 | 13 | 119 | 2 | IPR017943 | |
| Domain | Lipid-bd_serum_glycop_N | 3.00e-03 | 13 | 119 | 2 | IPR017942 | |
| Domain | Galactose-bd-like | 3.07e-03 | 94 | 119 | 4 | IPR008979 | |
| Domain | PLAC | 3.48e-03 | 14 | 119 | 2 | PF08686 | |
| Domain | Clathrin/coatomer_adapt-like_N | 4.00e-03 | 15 | 119 | 2 | IPR002553 | |
| Domain | Adaptin_N | 4.00e-03 | 15 | 119 | 2 | PF01602 | |
| Domain | Chemokine_rcpt | 4.56e-03 | 16 | 119 | 2 | IPR000355 | |
| Pathway | REACTOME_RECOGNITION_AND_ASSOCIATION_OF_DNA_GLYCOSYLASE_WITH_SITE_CONTAINING_AN_AFFECTED_PURINE | H2AB1 H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.94e-19 | 55 | 89 | 14 | M29526 |
| Pathway | REACTOME_REPLACEMENT_OF_PROTAMINES_BY_NUCLEOSOMES_IN_THE_MALE_PRONUCLEUS | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.24e-19 | 42 | 89 | 13 | M48029 |
| Pathway | REACTOME_BASE_EXCISION_REPAIR_AP_SITE_FORMATION | H2AB1 H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.25e-18 | 62 | 89 | 14 | M27700 |
| Pathway | REACTOME_DNA_METHYLATION | H2AB1 H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.04e-18 | 64 | 89 | 14 | M27429 |
| Pathway | REACTOME_ACTIVATED_PKN1_STIMULATES_TRANSCRIPTION_OF_AR_ANDROGEN_RECEPTOR_REGULATED_GENES_KLK2_AND_KLK3 | H2AB1 H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.27e-18 | 66 | 89 | 14 | M27488 |
| Pathway | REACTOME_SIRT1_NEGATIVELY_REGULATES_RRNA_EXPRESSION | H2AB1 H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 4.11e-18 | 67 | 89 | 14 | M27342 |
| Pathway | REACTOME_INHIBITION_OF_DNA_RECOMBINATION_AT_TELOMERE | H2AB1 H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 4.11e-18 | 67 | 89 | 14 | M39003 |
| Pathway | REACTOME_ASSEMBLY_OF_THE_ORC_COMPLEX_AT_THE_ORIGIN_OF_REPLICATION | H2AB1 H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 5.15e-18 | 68 | 89 | 14 | M27658 |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_THE_HUMAN_SILENCING_HUB_HUSH_COMPLEX | H2AB1 H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 8.00e-18 | 70 | 89 | 14 | M48261 |
| Pathway | REACTOME_CHROMATIN_MODIFICATIONS_DURING_THE_MATERNAL_TO_ZYGOTIC_TRANSITION_MZT | H2AB1 H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 8.00e-18 | 70 | 89 | 14 | M48028 |
| Pathway | REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE | H2AB1 H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.22e-17 | 72 | 89 | 14 | M29714 |
| Pathway | REACTOME_PRC2_METHYLATES_HISTONES_AND_DNA | H2AB1 H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.22e-17 | 72 | 89 | 14 | M27132 |
| Pathway | REACTOME_CONDENSATION_OF_PROPHASE_CHROMOSOMES | H2AB1 H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.51e-17 | 73 | 89 | 14 | M27166 |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PKNS | H2AB1 H2BC11 PPP1R12A H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.55e-17 | 93 | 89 | 15 | M27487 |
| Pathway | REACTOME_ERCC6_CSB_AND_EHMT2_G9A_POSITIVELY_REGULATE_RRNA_EXPRESSION | H2AB1 H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.26e-17 | 75 | 89 | 14 | M27343 |
| Pathway | REACTOME_MEIOTIC_SYNAPSIS | H2AB1 H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 4.07e-17 | 78 | 89 | 14 | M1061 |
| Pathway | REACTOME_DNA_DAMAGE_TELOMERE_STRESS_INDUCED_SENESCENCE | H2AB1 H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 4.92e-17 | 79 | 89 | 14 | M27191 |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | SEH1L H2AB1 H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.20e-16 | 106 | 89 | 15 | M27458 |
| Pathway | REACTOME_NONHOMOLOGOUS_END_JOINING_NHEJ | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.41e-16 | 68 | 89 | 13 | M27587 |
| Pathway | REACTOME_MEIOTIC_RECOMBINATION | H2AB1 H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.43e-16 | 88 | 89 | 14 | M1011 |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_GRANULOPOIESIS | H2AB1 H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.87e-16 | 89 | 89 | 14 | M27943 |
| Pathway | REACTOME_BASE_EXCISION_REPAIR | H2AB1 H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.38e-16 | 90 | 89 | 14 | M2158 |
| Pathway | REACTOME_RNA_POLYMERASE_I_PROMOTER_ESCAPE | H2AB1 H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.38e-16 | 90 | 89 | 14 | M27691 |
| Pathway | REACTOME_B_WICH_COMPLEX_POSITIVELY_REGULATES_RRNA_EXPRESSION | H2AB1 H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.38e-16 | 90 | 89 | 14 | M29668 |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | H2AB1 H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.98e-16 | 91 | 89 | 14 | M27101 |
| Pathway | REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION | H2AB1 H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 8.70e-16 | 96 | 89 | 14 | M27792 |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_PIWI_INTERACTING_RNAS_PIRNAS | H2AB1 H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.01e-15 | 97 | 89 | 14 | M48262 |
| Pathway | REACTOME_DNA_DOUBLE_STRAND_BREAK_RESPONSE | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.61e-15 | 78 | 89 | 13 | M27589 |
| Pathway | REACTOME_DNA_REPLICATION_PRE_INITIATION | H2AB1 H2BC11 MCM8 MCM5 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.77e-15 | 159 | 89 | 16 | M27665 |
| Pathway | REACTOME_DISEASES_OF_PROGRAMMED_CELL_DEATH | H2AB1 H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.78e-15 | 104 | 89 | 14 | M29829 |
| Pathway | REACTOME_POSITIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION | H2AB1 H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.19e-15 | 105 | 89 | 14 | M27425 |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_KRAB_ZFP_PROTEINS | H2AB1 H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 4.18e-15 | 107 | 89 | 14 | M48260 |
| Pathway | REACTOME_NEGATIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION | H2AB1 H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 4.78e-15 | 108 | 89 | 14 | M27426 |
| Pathway | REACTOME_AMYLOID_FIBER_FORMATION | H2AB1 H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 6.22e-15 | 110 | 89 | 14 | M27958 |
| Pathway | REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION | H2AB1 H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 6.22e-15 | 110 | 89 | 14 | M27696 |
| Pathway | REACTOME_SENESCENCE_ASSOCIATED_SECRETORY_PHENOTYPE_SASP | H2AB1 H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 7.09e-15 | 111 | 89 | 14 | M27187 |
| Pathway | KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS | H2AB1 H2AB2 H2BC11 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 7.70e-15 | 139 | 89 | 15 | M4741 |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | SEH1L H2AB1 H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 7.70e-15 | 139 | 89 | 15 | M715 |
| Pathway | REACTOME_TELOMERE_MAINTENANCE | H2AB1 H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 8.06e-15 | 112 | 89 | 14 | M4052 |
| Pathway | WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP | H2AB1 H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 8.06e-15 | 112 | 89 | 14 | M48334 |
| Pathway | REACTOME_MITOTIC_PROPHASE | SEH1L H2AB1 H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.06e-14 | 142 | 89 | 15 | M27660 |
| Pathway | REACTOME_HCMV_LATE_EVENTS | SEH1L H2BC11 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.33e-14 | 116 | 89 | 14 | M29806 |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | H2AB1 H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.92e-14 | 119 | 89 | 14 | M607 |
| Pathway | REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.03e-14 | 94 | 89 | 13 | M1080 |
| Pathway | REACTOME_HDACS_DEACETYLATE_HISTONES | H2BC11 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.03e-14 | 94 | 89 | 13 | M27230 |
| Pathway | REACTOME_MEIOSIS | H2AB1 H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.16e-14 | 120 | 89 | 14 | M529 |
| Pathway | REACTOME_ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS | H2AB1 H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.73e-14 | 122 | 89 | 14 | M29689 |
| Pathway | REACTOME_PROCESSING_OF_DNA_DOUBLE_STRAND_BREAK_ENDS | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.10e-14 | 97 | 89 | 13 | M27590 |
| Pathway | REACTOME_DNA_REPLICATION | H2AB1 H2BC11 MCM8 MCM5 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.65e-14 | 187 | 89 | 16 | M1017 |
| Pathway | REACTOME_OXIDATIVE_STRESS_INDUCED_SENESCENCE | H2AB1 H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.85e-14 | 125 | 89 | 14 | M27186 |
| Pathway | REACTOME_REPRODUCTION | H2AB1 H2BC11 H2BC12L PDPN H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 5.28e-14 | 158 | 89 | 15 | M26956 |
| Pathway | REACTOME_MATERNAL_TO_ZYGOTIC_TRANSITION_MZT | H2AB1 H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 5.38e-14 | 128 | 89 | 14 | M48019 |
| Pathway | REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_HSCS | H2AB1 H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 6.01e-14 | 129 | 89 | 14 | M27795 |
| Pathway | REACTOME_E3_UBIQUITIN_LIGASES_UBIQUITINATE_TARGET_PROTEINS | H2BC11 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC5 H2BC3 H2BC12 | 7.34e-14 | 59 | 89 | 11 | M27763 |
| Pathway | REACTOME_G2_M_CHECKPOINTS | H2BC11 MCM8 MCM5 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.20e-13 | 167 | 89 | 15 | M19381 |
| Pathway | REACTOME_HCMV_EARLY_EVENTS | SEH1L H2BC11 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.55e-13 | 138 | 89 | 14 | M29805 |
| Pathway | REACTOME_CHROMOSOME_MAINTENANCE | H2AB1 H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.72e-13 | 139 | 89 | 14 | M868 |
| Pathway | REACTOME_INHIBITION_OF_DNA_RECOMBINATION_AT_TELOMERE | 1.89e-13 | 31 | 89 | 9 | MM17225 | |
| Pathway | REACTOME_HATS_ACETYLATE_HISTONES | H2BC11 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC5 H2BC3 KAT6B | 2.03e-13 | 46 | 89 | 10 | MM14935 |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS | H2AB1 H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.31e-13 | 142 | 89 | 14 | M48257 |
| Pathway | REACTOME_HATS_ACETYLATE_HISTONES | H2BC11 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 KAT6B H2BC12 | 2.31e-13 | 142 | 89 | 14 | M27233 |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION | H2AB1 H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 4.53e-13 | 149 | 89 | 14 | M27888 |
| Pathway | REACTOME_CONDENSATION_OF_PROPHASE_CHROMOSOMES | 1.13e-12 | 37 | 89 | 9 | MM14883 | |
| Pathway | REACTOME_HCMV_INFECTION | SEH1L H2BC11 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.44e-12 | 162 | 89 | 14 | M29804 |
| Pathway | REACTOME_BASE_EXCISION_REPAIR_AP_SITE_FORMATION | 1.48e-12 | 38 | 89 | 9 | MM15434 | |
| Pathway | REACTOME_PRC2_METHYLATES_HISTONES_AND_DNA | 1.91e-12 | 39 | 89 | 9 | MM14850 | |
| Pathway | REACTOME_PROTEIN_UBIQUITINATION | H2BC11 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC5 H2BC3 H2BC12 | 2.14e-12 | 79 | 89 | 11 | M27742 |
| Pathway | REACTOME_CELL_CYCLE_CHECKPOINTS | SEH1L H2BC11 MCM8 MCM5 CLASP2 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.80e-12 | 291 | 89 | 17 | M16647 |
| Pathway | REACTOME_HOMOLOGY_DIRECTED_REPAIR | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.84e-12 | 140 | 89 | 13 | M27584 |
| Pathway | REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION | 6.23e-12 | 44 | 89 | 9 | MM15527 | |
| Pathway | REACTOME_RHO_GTPASE_EFFECTORS | SEH1L H2AB1 H2BC11 PPP1R12A CLASP2 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.48e-11 | 323 | 89 | 17 | M27080 |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | H2AB1 H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 ELF2 H2BC12 | 1.97e-11 | 237 | 89 | 15 | M27786 |
| Pathway | REACTOME_CELLULAR_SENESCENCE | H2AB1 H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.08e-11 | 197 | 89 | 14 | M27188 |
| Pathway | REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE | 2.14e-11 | 50 | 89 | 9 | MM15308 | |
| Pathway | REACTOME_DNA_DAMAGE_TELOMERE_STRESS_INDUCED_SENESCENCE | 4.44e-11 | 54 | 89 | 9 | MM14904 | |
| Pathway | REACTOME_DNA_DOUBLE_STRAND_BREAK_REPAIR | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 4.57e-11 | 170 | 89 | 13 | M27582 |
| Pathway | REACTOME_HDACS_DEACETYLATE_HISTONES | 5.28e-11 | 55 | 89 | 9 | MM14932 | |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS | 6.26e-11 | 56 | 89 | 9 | MM17236 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | SEH1L H2AB1 H2BC11 NET1 DSP PPP1R12A CLASP2 ADD3 H2BC12L DOCK5 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 EPHA2 H2BC5 H2BC3 PHIP H2BC12 | 6.59e-11 | 720 | 89 | 23 | M41838 |
| Pathway | REACTOME_ESR_MEDIATED_SIGNALING | H2AB1 H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 9.13e-11 | 220 | 89 | 14 | M27794 |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | RCE1 H2BC11 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 9.70e-11 | 221 | 89 | 14 | M27578 |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | H2AB1 H2BC11 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 KAT6B H2BC12 | 1.38e-10 | 272 | 89 | 15 | M29619 |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | H2AB1 H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.96e-10 | 233 | 89 | 14 | M27099 |
| Pathway | REACTOME_SIGNALING_BY_WNT | H2AB1 H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 AP2A1 AP2A2 H2BC5 H2BC3 H2BC12 | 2.13e-10 | 330 | 89 | 16 | M7847 |
| Pathway | REACTOME_BASE_EXCISION_REPAIR | 3.34e-10 | 67 | 89 | 9 | MM15429 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | H2AB1 H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 4.00e-10 | 246 | 89 | 14 | M10189 |
| Pathway | REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION | H2AB1 H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 6.09e-10 | 254 | 89 | 14 | M27131 |
| Pathway | REACTOME_TELOMERE_MAINTENANCE | 8.33e-10 | 74 | 89 | 9 | MM14605 | |
| Pathway | REACTOME_CELL_CYCLE_MITOTIC | SEH1L H2AB1 H2BC11 MCM8 PPP1R12A MCM5 CLASP2 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.55e-09 | 561 | 89 | 19 | M5336 |
| Pathway | REACTOME_MITOTIC_PROPHASE | SEH1L H2AB1 H2AB2 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC5 H2BC3 | 2.39e-09 | 114 | 89 | 10 | MM15361 |
| Pathway | REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS | H2AB1 H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 4.43e-09 | 296 | 89 | 14 | M27869 |
| Pathway | REACTOME_DEUBIQUITINATION | RCE1 H2BC11 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 5.04e-09 | 299 | 89 | 14 | M27574 |
| Pathway | REACTOME_M_PHASE | SEH1L H2AB1 H2BC11 CLASP2 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 6.31e-09 | 417 | 89 | 16 | M27662 |
| Pathway | REACTOME_E3_UBIQUITIN_LIGASES_UBIQUITINATE_TARGET_PROTEINS | 1.18e-08 | 45 | 89 | 7 | MM15508 | |
| Pathway | REACTOME_CHROMOSOME_MAINTENANCE | 1.50e-08 | 102 | 89 | 9 | MM15430 | |
| Pathway | REACTOME_NONHOMOLOGOUS_END_JOINING_NHEJ | 1.61e-08 | 47 | 89 | 7 | MM15296 | |
| Pathway | REACTOME_DNA_REPAIR | H2AB1 H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.91e-08 | 332 | 89 | 14 | M15434 |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | H2AB1 H2AB2 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC5 H2BC3 ELF2 | 4.12e-08 | 153 | 89 | 10 | MM15522 |
| Pathway | REACTOME_CELL_CYCLE | SEH1L H2AB1 H2BC11 MCM8 PPP1R12A MCM5 CLASP2 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 4.90e-08 | 694 | 89 | 19 | M543 |
| Pathway | REACTOME_CELLULAR_SENESCENCE | 5.79e-08 | 119 | 89 | 9 | MM14901 | |
| Pubmed | Inhibition of core histones acetylation by carcinogenic nickel(II). | H2BC11 H2BC18 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 8.26e-29 | 18 | 126 | 13 | 16283522 |
| Pubmed | H2BC11 H2BC18 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 4.74e-27 | 22 | 126 | 13 | 16713563 | |
| Pubmed | H2BC11 H2BC18 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.09e-26 | 23 | 126 | 13 | 16307923 | |
| Pubmed | Apoptotic phosphorylation of histone H2B is mediated by mammalian sterile twenty kinase. | H2BC11 H2BC18 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 5.44e-26 | 18 | 126 | 12 | 12757711 |
| Pubmed | H2BC11 H2BC18 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.44e-22 | 30 | 126 | 12 | 16319397 | |
| Pubmed | Histone H2B as a functionally important plasminogen receptor on macrophages. | 3.95e-19 | 15 | 126 | 9 | 17690254 | |
| Pubmed | H2BC11 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.48e-18 | 77 | 126 | 13 | 12408966 | |
| Pubmed | Quantitative proteomic analysis of post-translational modifications of human histones. | H2BC11 H2BC12L H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 H2BC12 | 1.91e-18 | 17 | 126 | 9 | 16627869 |
| Pubmed | 3.87e-18 | 11 | 126 | 8 | 15197225 | ||
| Pubmed | Histone modifications associated with somatic hypermutation. | 3.87e-18 | 11 | 126 | 8 | 16039583 | |
| Pubmed | Enhancement of the p300 HAT activity by HIV-1 Tat on chromatin DNA. | H2BC11 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.21e-17 | 69 | 126 | 12 | 11689053 |
| Pubmed | H2BC11 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 4.56e-17 | 73 | 126 | 12 | 14657027 | |
| Pubmed | H2BC11 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 4.56e-17 | 73 | 126 | 12 | 9566873 | |
| Pubmed | H2BC11 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.64e-16 | 86 | 126 | 12 | 11080476 | |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | H2BC11 PNN DSP PPP1R12A MCM5 ZC3H3 LUZP1 H2BC18 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 CGN H2BC5 ACIN1 H2BC3 H2BC12 | 8.33e-16 | 477 | 126 | 20 | 31300519 |
| Pubmed | H2BC11 DSP PCDH11Y H2BC18 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 5.54e-15 | 277 | 126 | 16 | 30745168 | |
| Pubmed | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC12 | 5.64e-14 | 67 | 126 | 10 | 25253489 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | H2BC11 INTS1 H2BC18 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 MKI67 H2BC5 ACIN1 H2BC3 H2BC12 | 7.64e-14 | 271 | 126 | 15 | 32433965 |
| Pubmed | H2BC11 PNN DSP PPP1R12A SMCHD1 MRPL53 MCM5 LUZP1 H2BC18 H2BC1 H2BC13 H2BC15 C2CD3 H2BC14 H2BC9 H2BC17 H2BC21 AP2A1 AP2A2 H2BC5 ACIN1 H2BC3 CFAP74 MYOM2 RIMS1 TAF4 H2BC12 DOP1A | 2.50e-13 | 1442 | 126 | 28 | 35575683 | |
| Pubmed | 4.44e-13 | 55 | 126 | 9 | 9439656 | ||
| Pubmed | H2AB1 H2AB2 H2BC11 DSP H2BC18 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 4.88e-13 | 438 | 126 | 17 | 21630459 | |
| Pubmed | Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. | H2BC11 H2BC18 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 5.94e-13 | 203 | 126 | 13 | 16916647 |
| Pubmed | Gene-specific characterization of human histone H2B by electron capture dissociation. | 3.45e-12 | 6 | 126 | 5 | 16457587 | |
| Pubmed | H2BC11 PPP1R12A MCM5 H2BC18 ADD3 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 LTA4H H2BC12 | 9.52e-12 | 451 | 126 | 16 | 36168627 | |
| Pubmed | Multi-omics profiling identifies a deregulated FUS-MAP1B axis in ALS/FTD-associated UBQLN2 mutants. | H2BC11 H2BC18 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.12e-11 | 256 | 126 | 13 | 35777956 |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | H2BC11 DSP PPP1R12A LUZP1 H2BC18 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 AP2A1 MKI67 H2BC5 H2BC3 H2BC12 | 1.42e-11 | 626 | 126 | 18 | 33644029 |
| Pubmed | H2BC11 MCM5 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC5 H2BC3 H2BC12 | 2.04e-11 | 212 | 126 | 12 | 23463506 | |
| Pubmed | H2BC11 DSP MUC16 MCM5 H2BC18 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 AP2A1 AP2A2 MKI67 H2BC5 H2BC3 H2BC12 | 3.05e-11 | 844 | 126 | 20 | 25963833 | |
| Pubmed | Regulation of error-prone translesion synthesis by Spartan/C1orf124. | 4.50e-11 | 59 | 126 | 8 | 23254330 | |
| Pubmed | Endotoxin-neutralizing antimicrobial proteins of the human placenta. | 8.19e-10 | 5 | 126 | 4 | 11859126 | |
| Pubmed | Biochemical and antibacterial analysis of human wound and blister fluid. | 8.19e-10 | 5 | 126 | 4 | 8620898 | |
| Pubmed | 1.12e-09 | 14 | 126 | 5 | 10064132 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | PNN DSP SMCHD1 LUZP1 H2BC18 H2BC12L H2BC1 H2BC13 ZC3H11A H2BC15 H2BC14 H2BC9 MKI67 H2BC5 ACIN1 ELF2 TAF4 PHIP H2BC12 | 1.78e-09 | 954 | 126 | 19 | 36373674 |
| Pubmed | SEH1L H2BC11 DSP H2BC18 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 AP2A1 AP2A2 H2BC5 H2BC3 LTA4H H2BC12 | 3.18e-09 | 878 | 126 | 18 | 37223481 | |
| Pubmed | H2BC18 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC21 H2BC5 ACIN1 H2BC3 | 4.53e-09 | 206 | 126 | 10 | 22174317 | |
| Pubmed | Antimicrobial peptides in the first line defence of human colon mucosa. | 4.75e-09 | 18 | 126 | 5 | 12860195 | |
| Pubmed | H2BC11 H2BC18 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 LTA4H H2BC12 | 5.53e-09 | 425 | 126 | 13 | 21081503 | |
| Pubmed | 5.70e-09 | 7 | 126 | 4 | 15019208 | ||
| Pubmed | H2BC11 PNN MYCBP2 DSP SMCHD1 INTS1 MCM5 PNPT1 H2BC13 ZC3H11A CGN MKI67 ACIN1 LTA4H PHIP | 1.63e-08 | 653 | 126 | 15 | 22586326 | |
| Pubmed | 1.14e-07 | 13 | 126 | 4 | 8858344 | ||
| Pubmed | H2BC11 DSP MRPL53 MCM5 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 AP2A1 AP2A2 H2BC5 H2BC3 H2BC12 | 1.96e-07 | 1153 | 126 | 18 | 29845934 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | SEH1L H2BC11 REPS1 PNN PPP1R12A ADCK1 INTS1 MRPL53 GLCCI1 LUZP1 H2BC17 H2BC21 AP2A1 AP2A2 EPHA2 H2BC3 | 2.07e-07 | 910 | 126 | 16 | 36736316 |
| Pubmed | 4.84e-07 | 80 | 126 | 6 | 25662211 | ||
| Pubmed | H2BC11 PNN DSP SMCHD1 INTS1 MCM5 H2BC12L H2BC13 ZC3H11A H2BC15 MKI67 H2BC5 H2BC12 | 7.72e-07 | 652 | 126 | 13 | 31180492 | |
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | SEMA4D PNN MYCBP2 DYNC2H1 SMCHD1 ZC3H11A AP2A1 MKI67 ACIN1 PHIP | 7.89e-07 | 358 | 126 | 10 | 32460013 |
| Pubmed | REPS1 PNN MYCBP2 DSP PPP1R12A SMCHD1 LUZP1 ADD3 ZC3H11A CGN ACIN1 TAF4 | 8.10e-07 | 549 | 126 | 12 | 38280479 | |
| Pubmed | 8.52e-07 | 88 | 126 | 6 | 26318153 | ||
| Pubmed | SEH1L H2BC11 PNN PPP1R12A SMCHD1 MCM5 LUZP1 AP2A1 AP2A2 EPHA2 MKI67 ACIN1 H2BC12 | 8.84e-07 | 660 | 126 | 13 | 32780723 | |
| Pubmed | Autoimmunity to isomerized histone H2B in systemic lupus erythematosus. | 9.21e-07 | 6 | 126 | 3 | 22967069 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | SEH1L PNN DSP SMCHD1 INTS1 DOCK5 ZC3H11A H2BC15 H2BC14 H2BC9 AP2A1 MKI67 H2BC5 ACIN1 ELF2 TAF4 SPTY2D1 H2BC12 | 1.04e-06 | 1294 | 126 | 18 | 30804502 |
| Pubmed | 1.58e-06 | 154 | 126 | 7 | 36490346 | ||
| Pubmed | Characterization of the 55-kb mouse histone gene cluster on chromosome 3. | 1.61e-06 | 7 | 126 | 3 | 8858345 | |
| Pubmed | The activity-dependent histone variant H2BE modulates the life span of olfactory neurons. | 1.61e-06 | 7 | 126 | 3 | 23240083 | |
| Pubmed | 2.57e-06 | 8 | 126 | 3 | 9710638 | ||
| Pubmed | 2.57e-06 | 8 | 126 | 3 | 11266453 | ||
| Pubmed | 3.53e-06 | 247 | 126 | 8 | 30713523 | ||
| Pubmed | 5.47e-06 | 10 | 126 | 3 | 24614311 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | SEMA4D CACNB3 MCM8 MYCBP2 PPP1R12A PCDH11Y FRMPD1 APBB2 CLASP2 TMEM255B DOCK5 PPP2R3A ZC3H11A PLXDC2 RIMS1 TAF4 KAT6B DOP1A | 7.32e-06 | 1489 | 126 | 18 | 28611215 |
| Pubmed | Human histone gene organization: nonregular arrangement within a large cluster. | 7.88e-06 | 35 | 126 | 4 | 9119399 | |
| Pubmed | SMCHD1 MCM5 H2BC18 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 AP2A1 H2BC5 | 1.28e-05 | 491 | 126 | 10 | 22623428 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 35809272 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 23054685 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 35264072 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 22829007 | ||
| Pubmed | Histone variant selectivity at the transcription start site: H2A.Z or H2A.Lap1. | 1.30e-05 | 2 | 126 | 2 | 24213378 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 8611618 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 16574316 | ||
| Pubmed | Chemokine receptor mRNA expression at the in vitro blood-brain barrier during HIV infection. | 1.30e-05 | 2 | 126 | 2 | 10094132 | |
| Pubmed | Cloning of cDNAs encoding two related 100-kD coated vesicle proteins (alpha-adaptins). | 1.30e-05 | 2 | 126 | 2 | 2564002 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 26077903 | ||
| Pubmed | KSHV enhances mesenchymal stem cell homing and promotes KS-like pathogenesis. | 1.30e-05 | 2 | 126 | 2 | 32777727 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 12794150 | ||
| Pubmed | The mouse pink-eyed unstable mutation: a DNA duplication revealed by genome scanning. | 1.30e-05 | 2 | 126 | 2 | 1409429 | |
| Pubmed | MCM5 Expression Is Associated With the Grade of Malignancy and Ki-67 Antigen in LSCC. | 1.30e-05 | 2 | 126 | 2 | 31092424 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 28234895 | ||
| Pubmed | Cloning, physical mapping and structural characterization of the human alpha(A)-adaptin gene. | 1.30e-05 | 2 | 126 | 2 | 12036598 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 25986216 | ||
| Pubmed | Gene editing of the multi-copy H2A.B gene and its importance for fertility. | 1.30e-05 | 2 | 126 | 2 | 30704500 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 24768041 | ||
| Pubmed | H2A.Bbd: an X-chromosome-encoded histone involved in mammalian spermiogenesis. | 1.30e-05 | 2 | 126 | 2 | 20008104 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | H2BC11 DSP MRPL53 MCM5 H2BC13 H2BC15 H2BC14 H2BC4 H2BC17 H2BC5 H2BC3 H2BC12 DOP1A | 1.32e-05 | 847 | 126 | 13 | 35235311 |
| Pubmed | 1.59e-05 | 86 | 126 | 5 | 37253089 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | PNN MYCBP2 DSP SMCHD1 INTS1 MCM5 ZC3H11A H2BC15 H2BC21 AP2A1 CGN MKI67 ACIN1 PHIP | 2.18e-05 | 1024 | 126 | 14 | 24711643 |
| Pubmed | 2.51e-05 | 16 | 126 | 3 | 29764992 | ||
| Pubmed | 2.84e-05 | 97 | 126 | 5 | 22360420 | ||
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 3.62e-05 | 341 | 126 | 8 | 32971831 | |
| Pubmed | 3.64e-05 | 18 | 126 | 3 | 23211419 | ||
| Pubmed | 3.72e-05 | 250 | 126 | 7 | 33536335 | ||
| Pubmed | A unique H2A histone variant occupies the transcriptional start site of active genes. | 3.90e-05 | 3 | 126 | 2 | 22139013 | |
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 35014951 | ||
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 18032517 | ||
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 22262466 | ||
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 20694513 | ||
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 27163153 | ||
| Pubmed | TAF4 inactivation reveals the 3 dimensional growth promoting activities of collagen 6A3. | 3.90e-05 | 3 | 126 | 2 | 24498316 | |
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 12837268 | ||
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 26269175 | ||
| Pubmed | Nucleosomes containing the histone variant H2A.Bbd organize only 118 base pairs of DNA. | 3.90e-05 | 3 | 126 | 2 | 15257289 | |
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 11832479 | ||
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 3562244 | ||
| Interaction | TNN interactions | H2BC11 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.45e-21 | 23 | 120 | 12 | int:TNN |
| Interaction | CDK5R2 interactions | H2BC11 H2BC18 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.66e-19 | 23 | 120 | 11 | int:CDK5R2 |
| Interaction | CYLC1 interactions | H2BC11 H2BC18 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 6.71e-18 | 20 | 120 | 10 | int:CYLC1 |
| Interaction | HMGN3 interactions | H2BC11 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 6.18e-17 | 64 | 120 | 13 | int:HMGN3 |
| Interaction | DUOX2 interactions | H2BC11 H2BC18 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.04e-15 | 30 | 120 | 10 | int:DUOX2 |
| Interaction | H2BC17 interactions | H2BC11 MCM5 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 KAT6B H2BC12 | 5.01e-15 | 140 | 120 | 15 | int:H2BC17 |
| Interaction | H2BC15 interactions | H2AB2 H2BC11 MCM5 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 7.67e-15 | 144 | 120 | 15 | int:H2BC15 |
| Interaction | TEX35 interactions | H2BC11 H2BC18 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.06e-14 | 57 | 120 | 11 | int:TEX35 |
| Interaction | H2AC7 interactions | H2BC11 MCM5 H2BC18 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 6.89e-14 | 107 | 120 | 13 | int:H2AC7 |
| Interaction | H2AC25 interactions | H2BC11 MCM5 H2BC18 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 8.92e-14 | 84 | 120 | 12 | int:H2AC25 |
| Interaction | H2BC13 interactions | H2AB2 H2BC11 MCM5 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 MKI67 H2BC5 H2BC3 H2BC12 | 1.30e-13 | 210 | 120 | 16 | int:H2BC13 |
| Interaction | H2BC11 interactions | H2AB2 H2BC11 MCM5 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.45e-13 | 186 | 120 | 15 | int:H2BC11 |
| Interaction | FAM47B interactions | 3.70e-13 | 13 | 120 | 7 | int:FAM47B | |
| Interaction | H2BC12 interactions | H2AB2 H2BC11 PNN SMCHD1 MCM5 CLASP2 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 7.15e-13 | 322 | 120 | 18 | int:H2BC12 |
| Interaction | H2BC14 interactions | H2BC11 MCM5 H2BC18 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 7.66e-13 | 100 | 120 | 12 | int:H2BC14 |
| Interaction | H2AC6 interactions | H2BC11 MCM5 H2BC18 H2BC1 H2BC13 H2BC15 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 7.66e-13 | 100 | 120 | 12 | int:H2AC6 |
| Interaction | HMGN4 interactions | H2BC11 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 7.66e-13 | 100 | 120 | 12 | int:HMGN4 |
| Interaction | LOC102724334 interactions | H2BC11 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.31e-12 | 134 | 120 | 13 | int:LOC102724334 |
| Interaction | DPPA2 interactions | H2BC11 H2BC18 H2BC13 H2BC15 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.62e-12 | 40 | 120 | 9 | int:DPPA2 |
| Interaction | H2BC4 interactions | H2BC11 PNN SMCHD1 MCM5 CLASP2 H2BC18 H2BC1 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.28e-12 | 259 | 120 | 16 | int:H2BC4 |
| Interaction | H2BC18 interactions | H2BC11 MCM5 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.63e-12 | 180 | 120 | 14 | int:H2BC18 |
| Interaction | ZNF474 interactions | H2BC11 H2BC18 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 H2BC12 | 4.13e-12 | 44 | 120 | 9 | int:ZNF474 |
| Interaction | H2AC18 interactions | H2BC11 MCM5 H2BC18 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 TAF4 H2BC12 | 4.73e-12 | 148 | 120 | 13 | int:H2AC18 |
| Interaction | H2AC12 interactions | H2BC11 MCM5 H2BC18 H2BC15 C2CD3 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 5.69e-12 | 118 | 120 | 12 | int:H2AC12 |
| Interaction | HCLS1 interactions | H2BC11 H2BC18 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.30e-11 | 71 | 120 | 10 | int:HCLS1 |
| Interaction | H2AC1 interactions | H2BC11 MCM5 H2BC18 H2BC1 H2BC15 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.30e-11 | 71 | 120 | 10 | int:H2AC1 |
| Interaction | H2BC9 interactions | H2BC11 PNN DSP MCM5 ADGRG4 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 TAF4 KAT6B H2BC12 | 1.83e-11 | 446 | 120 | 19 | int:H2BC9 |
| Interaction | H2AC11 interactions | H2BC11 MCM5 ZC3H3 H2BC18 H2BC1 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 TAF4 H2BC12 | 2.21e-11 | 248 | 120 | 15 | int:H2AC11 |
| Interaction | H2BC1 interactions | H2BC11 MCM5 H2BC18 H2BC1 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 4.93e-11 | 178 | 120 | 13 | int:H2BC1 |
| Interaction | MCM5 interactions | H2BC11 MCM8 DSP MCM5 H2BC18 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 MKI67 H2BC5 H2BC3 H2BC12 | 5.94e-11 | 420 | 120 | 18 | int:MCM5 |
| Interaction | H2AC14 interactions | H2BC11 MCM5 H2BC18 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 MKI67 H2BC5 H2BC3 H2BC12 | 6.07e-11 | 144 | 120 | 12 | int:H2AC14 |
| Interaction | H2BC26 interactions | H2BC11 MCM5 H2BC18 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 6.99e-11 | 183 | 120 | 13 | int:H2BC26 |
| Interaction | JPH2 interactions | 9.78e-11 | 25 | 120 | 7 | int:JPH2 | |
| Interaction | H2BC5 interactions | H2BC11 MCM5 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 MKI67 H2BC5 H2BC3 TAF4 H2BC12 | 1.30e-10 | 331 | 120 | 16 | int:H2BC5 |
| Interaction | PCLO interactions | H2BC11 H2BC18 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 H2BC12 | 3.33e-10 | 70 | 120 | 9 | int:PCLO |
| Interaction | H2AC13 interactions | H2BC11 H2BC18 H2BC13 H2BC15 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 6.27e-10 | 75 | 120 | 9 | int:H2AC13 |
| Interaction | SFMBT2 interactions | 6.62e-10 | 32 | 120 | 7 | int:SFMBT2 | |
| Interaction | HMGN2 interactions | H2BC11 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 7.67e-10 | 222 | 120 | 13 | int:HMGN2 |
| Interaction | H2BC21 interactions | H2BC11 PNN SMCHD1 MCM5 H2BC18 H2BC1 H2BC13 H2BC15 C2CD3 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 MKI67 H2BC5 H2BC3 BPIFB2 KAT6B PHIP H2BC12 | 8.44e-10 | 696 | 120 | 21 | int:H2BC21 |
| Interaction | PINK1 interactions | H2BC11 PNN DSP PPP1R12A MCM5 ZC3H3 LUZP1 H2BC18 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 CGN H2BC5 ACIN1 H2BC3 H2BC12 | 3.37e-09 | 679 | 120 | 20 | int:PINK1 |
| Interaction | H2AJ interactions | H2BC11 MCM5 H2BC18 H2BC13 H2BC15 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 4.46e-09 | 127 | 120 | 10 | int:H2AJ |
| Interaction | ARHGAP24 interactions | H2BC11 PNN PPP1R12A MCM5 H2BC18 ADD3 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 LTA4H H2BC12 | 4.61e-09 | 486 | 120 | 17 | int:ARHGAP24 |
| Interaction | UBA52 interactions | H2BC11 PPP1R12A MCM5 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 TAF4 H2BC12 | 7.18e-09 | 437 | 120 | 16 | int:UBA52 |
| Interaction | PDS5B interactions | H2BC11 H2BC18 NPTN H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 9.44e-09 | 178 | 120 | 11 | int:PDS5B |
| Interaction | H3C1 interactions | H2BC11 DSP DYNC2H1 SMCHD1 INTS1 MCM5 H2BC18 H2BC1 H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 MKI67 H2BC5 H2BC3 ELF2 TAF4 KAT6B PHIP H2BC12 | 1.55e-08 | 901 | 120 | 22 | int:H3C1 |
| Interaction | H2AC21 interactions | H2BC11 MCM5 ZC3H3 H2BC18 H2BC1 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 CCR1 | 1.58e-08 | 234 | 120 | 12 | int:H2AC21 |
| Interaction | RPS27A interactions | H2BC11 NET1 MCM5 ZC3H3 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 TAF4 H2BC12 | 1.96e-08 | 536 | 120 | 17 | int:RPS27A |
| Interaction | IGSF8 interactions | H2BC11 MCM5 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC5 H2BC3 H2BC12 | 2.00e-08 | 239 | 120 | 12 | int:IGSF8 |
| Interaction | HMGA1 interactions | H2BC11 DSP ADCK1 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 PHIP H2BC12 | 2.96e-08 | 419 | 120 | 15 | int:HMGA1 |
| Interaction | CD81 interactions | H2BC11 MYCBP2 MCM5 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC5 H2BC3 H2BC12 | 3.22e-08 | 303 | 120 | 13 | int:CD81 |
| Interaction | ADARB1 interactions | H2BC11 H2BC18 PNPT1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 MKI67 H2BC5 ACIN1 H2BC3 SPTY2D1 H2BC12 | 3.46e-08 | 489 | 120 | 16 | int:ADARB1 |
| Interaction | H2AZ1 interactions | H2BC11 MCM5 H2BC18 H2BC1 H2BC13 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 TAF4 PHIP H2BC12 | 4.61e-08 | 371 | 120 | 14 | int:H2AZ1 |
| Interaction | BTF3 interactions | SEH1L H2BC11 PNN DSP PPP1R12A LUZP1 H2BC18 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 AP2A1 MKI67 H2BC5 H2BC3 H2BC12 | 5.09e-08 | 799 | 120 | 20 | int:BTF3 |
| Interaction | H2AC4 interactions | H2BC11 MRPL27 MCM5 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 TAF4 H2BC12 | 5.54e-08 | 506 | 120 | 16 | int:H2AC4 |
| Interaction | H2AC20 interactions | H2BC11 MCM5 H2BC18 H2BC1 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 CCR1 PHIP H2BC12 | 6.11e-08 | 320 | 120 | 13 | int:H2AC20 |
| Interaction | ELK4 interactions | 7.66e-08 | 92 | 120 | 8 | int:ELK4 | |
| Interaction | TMEM196 interactions | 8.22e-08 | 8 | 120 | 4 | int:TMEM196 | |
| Interaction | PSMD14 interactions | H2BC11 DSP PCDH11Y H2BC18 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 9.66e-08 | 527 | 120 | 16 | int:PSMD14 |
| Interaction | UBB interactions | H2AB1 H2BC11 FUZ MCM5 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.22e-07 | 467 | 120 | 15 | int:UBB |
| Interaction | H2BC3 interactions | H2BC11 MCM5 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.40e-07 | 406 | 120 | 14 | int:H2BC3 |
| Interaction | ICAM1 interactions | H2BC11 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC5 H2BC3 H2BC12 | 3.28e-07 | 252 | 120 | 11 | int:ICAM1 |
| Interaction | H3C15 interactions | H2BC11 DSP MCM5 H2BC1 H2BC13 H2BC9 H2BC4 H2BC21 H2BC5 H2BC12 | 4.57e-07 | 207 | 120 | 10 | int:H3C15 |
| Interaction | H2AZ2 interactions | 7.43e-07 | 168 | 120 | 9 | int:H2AZ2 | |
| Interaction | HMGN1 interactions | 7.43e-07 | 168 | 120 | 9 | int:HMGN1 | |
| Interaction | ADAMTS12 interactions | 8.98e-07 | 55 | 120 | 6 | int:ADAMTS12 | |
| Interaction | PDCD4 interactions | 1.10e-06 | 176 | 120 | 9 | int:PDCD4 | |
| Interaction | MCM2 interactions | H2BC11 DSP MUC16 MCM5 H2BC18 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 AP2A1 AP2A2 EPHA2 MKI67 H2BC5 H2BC3 H2BC12 | 1.51e-06 | 1081 | 120 | 21 | int:MCM2 |
| Interaction | H3-7 interactions | 1.65e-06 | 137 | 120 | 8 | int:H3-7 | |
| Interaction | TTN interactions | MYCBP2 DSP H2BC18 H2BC13 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 MYOM2 H2BC12 | 1.77e-06 | 299 | 120 | 11 | int:TTN |
| Interaction | H2AX interactions | H2BC11 MCM5 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 MKI67 H2BC5 H2BC3 H2BC12 | 2.46e-06 | 593 | 120 | 15 | int:H2AX |
| Interaction | CKAP5 interactions | SEH1L H2BC11 DSP MCM5 CLASP2 H2BC13 H2BC9 H2BC4 H2BC5 CCR1 H2BC12 | 3.61e-06 | 322 | 120 | 11 | int:CKAP5 |
| Interaction | MAP7D2 interactions | 3.78e-06 | 70 | 120 | 6 | int:MAP7D2 | |
| Interaction | MAP1B interactions | H2BC11 H2BC18 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 MKI67 H2BC5 H2BC3 H2BC12 | 4.04e-06 | 539 | 120 | 14 | int:MAP1B |
| Interaction | EIF1AX interactions | 5.10e-06 | 113 | 120 | 7 | int:EIF1AX | |
| Interaction | USF3 interactions | 5.38e-06 | 20 | 120 | 4 | int:USF3 | |
| Interaction | H3-5 interactions | 5.41e-06 | 114 | 120 | 7 | int:H3-5 | |
| Interaction | DOK2 interactions | 6.07e-06 | 116 | 120 | 7 | int:DOK2 | |
| Interaction | SMC5 interactions | PNN DSP SMCHD1 LUZP1 H2BC18 H2BC12L H2BC1 H2BC13 ZC3H11A H2BC15 H2BC14 H2BC9 MKI67 H2BC5 ACIN1 ELF2 TAF4 PHIP H2BC12 | 6.98e-06 | 1000 | 120 | 19 | int:SMC5 |
| Interaction | XPC interactions | 7.51e-06 | 168 | 120 | 8 | int:XPC | |
| Interaction | HEXIM1 interactions | H2BC11 DSP MCM5 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 AP2A1 AP2A2 EPHA2 H2BC5 H2BC3 H2BC12 | 7.59e-06 | 913 | 120 | 18 | int:HEXIM1 |
| Interaction | TMA7 interactions | 7.76e-06 | 46 | 120 | 5 | int:TMA7 | |
| Interaction | ACTR6 interactions | 8.65e-06 | 47 | 120 | 5 | int:ACTR6 | |
| Interaction | SIRT7 interactions | H2BC11 PNN MYCBP2 DSP SMCHD1 INTS1 MCM5 PNPT1 H2BC13 ZC3H11A H2BC21 CGN MKI67 ACIN1 LTA4H PHIP | 8.79e-06 | 744 | 120 | 16 | int:SIRT7 |
| Interaction | CCL3 interactions | 1.15e-05 | 178 | 120 | 8 | int:CCL3 | |
| Interaction | IPO9 interactions | 1.20e-05 | 236 | 120 | 9 | int:IPO9 | |
| Interaction | H3-4 interactions | H2BC11 MCM5 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC21 H2BC5 TAF4 KAT6B H2BC12 | 1.52e-05 | 448 | 120 | 12 | int:H3-4 |
| Interaction | SCAF1 interactions | 1.72e-05 | 136 | 120 | 7 | int:SCAF1 | |
| Interaction | WDR76 interactions | H2BC11 DSP SMCHD1 INTS1 MCM5 H2BC17 H2BC21 MKI67 H2BC5 PHIP H2BC12 | 1.84e-05 | 383 | 120 | 11 | int:WDR76 |
| Interaction | TNRC18 interactions | 1.85e-05 | 92 | 120 | 6 | int:TNRC18 | |
| Interaction | PRKCB interactions | 2.23e-05 | 255 | 120 | 9 | int:PRKCB | |
| Interaction | OSBPL9 interactions | 2.35e-05 | 96 | 120 | 6 | int:OSBPL9 | |
| Interaction | MAPK7 interactions | 2.38e-05 | 143 | 120 | 7 | int:MAPK7 | |
| Interaction | LUZP4 interactions | 2.80e-05 | 99 | 120 | 6 | int:LUZP4 | |
| Interaction | RIOK1 interactions | H2BC11 H2BC18 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 LTA4H H2BC12 | 3.08e-05 | 562 | 120 | 13 | int:RIOK1 |
| Interaction | C11orf58 interactions | 3.14e-05 | 101 | 120 | 6 | int:C11orf58 | |
| Interaction | SPON2 interactions | 3.28e-05 | 11 | 120 | 3 | int:SPON2 | |
| Interaction | TOMM70 interactions | 3.68e-05 | 153 | 120 | 7 | int:TOMM70 | |
| Interaction | KNOP1 interactions | 3.69e-05 | 272 | 120 | 9 | int:KNOP1 | |
| Interaction | H2AB2 interactions | 4.35e-05 | 107 | 120 | 6 | int:H2AB2 | |
| Interaction | H4C9 interactions | 4.59e-05 | 108 | 120 | 6 | int:H4C9 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6p22 | H2BC11 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC5 H2BC3 H2BC12 | 8.90e-09 | 378 | 126 | 11 | chr6p22 |
| Cytoband | 6p22.1 | 2.86e-06 | 142 | 126 | 6 | 6p22.1 | |
| GeneFamily | Histones | H2AB1 H2AB2 H2BC11 H2BC18 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.02e-19 | 116 | 83 | 16 | 864 |
| GeneFamily | Cadherin related | 6.06e-05 | 17 | 83 | 3 | 24 | |
| GeneFamily | Zinc fingers CCCH-type | 5.49e-04 | 35 | 83 | 3 | 73 | |
| GeneFamily | MCM family | 7.34e-04 | 9 | 83 | 2 | 1085 | |
| GeneFamily | CD molecules|C-C motif chemokine receptors | 9.15e-04 | 10 | 83 | 2 | 1091 | |
| GeneFamily | Immunoglobulin like domain containing | 1.95e-03 | 193 | 83 | 5 | 594 | |
| GeneFamily | BPI fold containing | 2.40e-03 | 16 | 83 | 2 | 456 | |
| GeneFamily | CD molecules|Mucins | 4.13e-03 | 21 | 83 | 2 | 648 | |
| Coexpression | GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_24H_DN | H2BC11 DAG1 H2BC13 H2BC15 H2BC14 H2BC4 H2BC21 H2BC5 LTA4H H2BC12 | 4.42e-08 | 200 | 125 | 10 | M9952 |
| Coexpression | ZENG_GU_ICB_CONTROL_METAGENE_14_PRECICTIVE_ICB_RESPONSE | 4.80e-07 | 198 | 125 | 9 | MM17083 | |
| Coexpression | HASLINGER_B_CLL_WITH_6Q21_DELETION | 3.37e-06 | 22 | 125 | 4 | M7362 | |
| Coexpression | GSE19401_PLN_VS_PEYERS_PATCH_FOLLICULAR_DC_DN | 5.28e-06 | 199 | 125 | 8 | M7667 | |
| Coexpression | DAZARD_UV_RESPONSE_CLUSTER_G6 | 6.34e-06 | 145 | 125 | 7 | M1810 | |
| Coexpression | MARSON_BOUND_BY_E2F4_UNSTIMULATED | H2BC11 MCM8 NET1 MRPL27 MCM5 H2BC18 H2BC13 H2BC9 H2BC4 H2BC17 H2BC5 H2BC3 H2BC12 RAD54L | 8.24e-06 | 714 | 125 | 14 | M1744 |
| Coexpression | JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_UP | MCM8 INTS1 PCDHB9 MRPL27 GRIN2C PNPT1 PLIN5 H2BC5 H2BC3 CFAP74 | 1.47e-05 | 380 | 125 | 10 | M38974 |
| Coexpression | DURCHDEWALD_SKIN_CARCINOGENESIS_UP | 1.57e-05 | 111 | 125 | 6 | MM705 | |
| Coexpression | RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN | 1.74e-05 | 113 | 125 | 6 | M9524 | |
| Coexpression | NUYTTEN_NIPP1_TARGETS_UP | SEH1L H2BC11 PNN H2BC12L PNPT1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.86e-05 | 768 | 125 | 14 | M6444 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_T_CELL | SEH1L H2BC11 MCM8 NET1 MCM5 ZC3H3 H2BC18 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 MKI67 H2BC3 RAD54L | 4.24e-05 | 939 | 125 | 15 | M45768 |
| Coexpression | EGFR_UP.V1_DN | 4.45e-05 | 196 | 125 | 7 | M2633 | |
| Coexpression | GSE43260_BTLA_POS_VS_NEG_INTRATUMORAL_CD8_TCELL_DN | 4.90e-05 | 199 | 125 | 7 | M9954 | |
| Coexpression | GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_UP | 5.06e-05 | 200 | 125 | 7 | M6306 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_CYCLING_DEFINITIVE_ERYTHROBLAST | H2BC11 ISOC1 MCM5 H2BC18 H2BC15 H2BC9 H2BC4 MKI67 H2BC3 RAD54L | 6.16e-05 | 450 | 125 | 10 | M45747 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | MYCBP2 PPP1R12A SMCHD1 CLASP2 FAT1 PPP2R3A C2CD3 TAF4 KAT6B PHIP | 8.22e-05 | 466 | 125 | 10 | M13522 |
| Coexpression | BENPORATH_MYC_MAX_TARGETS | H2BC11 PPP1R12A PEX6 MCM5 TSC2 H2BC12L H2BC15 H2BC14 H2BC9 H2BC4 H2BC21 LTA4H RAD54L | 8.72e-05 | 775 | 125 | 13 | M17753 |
| Coexpression | DURCHDEWALD_SKIN_CARCINOGENESIS_UP | 9.84e-05 | 96 | 125 | 5 | M1683 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 9.91e-05 | 300 | 125 | 8 | M8702 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_NK_CELL | H2BC11 MCM8 FUZ MCM5 H2BC18 H2BC13 H2BC15 H2BC9 H2BC4 MKI67 H2BC3 RAD54L | 1.24e-04 | 694 | 125 | 12 | M45767 |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_LARGE_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | 1.37e-04 | 402 | 125 | 9 | MM454 | |
| Coexpression | DANG_BOUND_BY_MYC | H2BC11 PPP1R12A PEX6 MCM5 TSC2 OCA2 H2BC12L H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 LTA4H RAD54L | 1.65e-04 | 1061 | 125 | 15 | M15774 |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_nonFloor_2500_K4 | 5.07e-09 | 70 | 118 | 8 | facebase_RNAseq_e8.5_NeuroEpith_nonFloor_2500_K4 | |
| CoexpressionAtlas | mendel_RNAseq_e17.5_Urothelium_ShhCreRFP_2500_K3 | 2.09e-08 | 32 | 118 | 6 | mendel_RNAseq_e17.5_Urothelium_ShhCreRFP_2500_K3 | |
| CoexpressionAtlas | facebase_RNAseq_e9.5_MandArch_2500_K1 | H2BC11 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC17 H2BC5 H2BC12 | 3.31e-08 | 125 | 118 | 9 | facebase_RNAseq_e9.5_MandArch_2500_K1 |
| CoexpressionAtlas | gudmap_RNAseq_e11.5_Ureteric_bud_2500_K2 | 3.37e-07 | 50 | 118 | 6 | gudmap_RNAseq_e11.5_Ureteric_bud_2500_K2 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_ParaxMesoderm_2500_K0 | 2.71e-06 | 110 | 118 | 7 | facebase_RNAseq_e8.5_ParaxMesoderm_2500_K0 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K1 | 3.00e-06 | 72 | 118 | 6 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K1 | |
| CoexpressionAtlas | facebase_RNAseq_e9.5_FaceMes_2500_K2 | 1.24e-05 | 54 | 118 | 5 | facebase_RNAseq_e9.5_FaceMes_2500_K2 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K4 | 1.76e-05 | 58 | 118 | 5 | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K4 | |
| CoexpressionAtlas | gudmap_RNAseq_e15.5_Mesangium_2500_K4 | 3.43e-05 | 162 | 118 | 7 | gudmap_RNAseq_e15.5_Mesangium_2500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_2500_k-means-cluster#1 | DAG1 CCDC80 H2BC18 H2BC1 H2BC15 H2BC14 H2BC17 ADAMTS17 H2BC3 | 4.63e-05 | 300 | 118 | 9 | Facebase_RNAseq_e9.5_Olfactory Placode_2500_K1 |
| CoexpressionAtlas | kidney_adult_Podocyte_MafB_top-relative-expression-ranked_1000 | PCSK5 ILDR2 APBB2 DAG1 IFI27 LUZP1 DOCK5 PDPN NPTN FAT1 H2BC4 H2BC21 PLXDC2 EPHA2 MYOM2 | 6.35e-05 | 838 | 118 | 15 | gudmap_kidney_adult_Podocyte_MafB_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_OlfacPit_2500_K1 | H2BC11 DSP H2BC1 H2BC13 H2BC15 H2BC14 H2BC17 CGN H2BC5 H2BC12 | 8.38e-05 | 402 | 118 | 10 | facebase_RNAseq_e10.5_OlfacPit_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_500_k-means-cluster#1 | 8.39e-05 | 80 | 118 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_500_K1 | |
| CoexpressionAtlas | gudmap_RNAseq_e15.5_Podocytes_2500_K1 | 9.46e-05 | 43 | 118 | 4 | gudmap_RNAseq_e15.5_Podocytes_2500_K1 | |
| CoexpressionAtlas | B cells, preB.FrC.BM, CD19+ IgM- CD45R+ CD43+ HSA+, Bone marrow, avg-3 | MCM8 DYNC2H1 MCM5 H2BC13 H2BC14 H2BC9 EPHA2 MKI67 H2BC3 RAD54L | 9.66e-05 | 409 | 118 | 10 | GSM399452_500 |
| CoexpressionAtlas | kidney_adult_RenCorpuscGlomer_k-means-cluster#3_top-relative-expression-ranked_500 | 1.38e-04 | 141 | 118 | 6 | gudmap_kidney_adult_RenCorpuscGlomer_k3_500 | |
| CoexpressionAtlas | gudmap_RNAseq_e11.5_Ureteric_stalks_2500_K1 | 2.00e-04 | 52 | 118 | 4 | gudmap_RNAseq_e11.5_Ureteric_stalks_2500_K1 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_FloorPlate_2500_K2 | 2.47e-04 | 157 | 118 | 6 | facebase_RNAseq_e8.5_FloorPlate_2500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_500_k-means-cluster#3 | 3.44e-04 | 108 | 118 | 5 | Facebase_RNAseq_e9.5_Olfactory Placode_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | 3.51e-04 | 311 | 118 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K4 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_k-means-cluster#2_top-relative-expression-ranked_500 | 3.52e-04 | 25 | 118 | 3 | gudmap_kidney_adult_RenalCapsule_k2_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_500 | 3.62e-04 | 482 | 118 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_500 | |
| CoexpressionAtlas | alpha beta T cells, preT.DN3-4.Th, Lin-/lo CD25int CD44- CD28+, Thymus, avg-3 | 3.79e-04 | 397 | 118 | 9 | GSM791143_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_500 | ILDR2 SEMA4D VAX1 GDPD2 IGSF11 H2BC14 AJAP1 CGN PCDH15 H2BC3 | 4.05e-04 | 489 | 118 | 10 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_500 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_500 | 4.19e-04 | 491 | 118 | 10 | Facebase_RNAseq_e9.5_Olfactory Placode_500 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg1+vd6+.Th.TCRbko, TCRd+ Vg1.1+ Vd6.3+, Thymus, avg-3 | 4.90e-04 | 327 | 118 | 8 | GSM605778_500 | |
| CoexpressionAtlas | kidney_adult_Podocyte_MafB_top-relative-expression-ranked_200 | 4.98e-04 | 179 | 118 | 6 | gudmap_kidney_adult_Podocyte_MafB_200 | |
| CoexpressionAtlas | B cells, proB.CLP.FL, CD19- IgM- CD43+ CD24intermediate CD45R- AA4.1+ CD, Fetal Liver, avg-1 | 5.50e-04 | 418 | 118 | 9 | GSM538350_500 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg3+24alo.e17.Th, TCRd+ Vg3+ CD24-, Fetal Thymus, avg-3 | 5.60e-04 | 419 | 118 | 9 | GSM476664_500 | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.17e-09 | 192 | 126 | 9 | 0dc1f46e40346ed0b286e53b106a812441575100 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.99e-09 | 196 | 126 | 9 | 1964c5003a0cb84539850a7cfe3bbb0e23a61d2d | |
| ToppCell | Control-Lymphocyte-B-Plasmablast|Control / Disease, Lineage and Cell Type | 2.08e-08 | 162 | 126 | 8 | 67b32c40cc180c5ebbfd901a417b5be469500110 | |
| ToppCell | ILEUM-non-inflamed-(7)_Endothelial_cell-(7)_Lymphatics|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 7.16e-08 | 190 | 126 | 8 | 9ce301841ce9486701fa28eb2a9929e35d476878 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 7.76e-08 | 192 | 126 | 8 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.02e-07 | 199 | 126 | 8 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | NS-critical-d_07-13-Lymphoid-NKT-proliferating|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.06e-07 | 200 | 126 | 8 | 7f5cd05bb1b9a83baceddb7d7f0a9ec9781cda29 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.62e-07 | 170 | 126 | 7 | b1a16600754e0c12f7d39c9221f1b03135833f16 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.57e-07 | 174 | 126 | 7 | 021ebc6ec022b992d7b25333ba0b7416371e041b | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.57e-07 | 174 | 126 | 7 | c2fc78dd6c440737ded59676961e4c7b923084ce | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_goblet_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.37e-07 | 177 | 126 | 7 | a4c001a8e44142babf9f24dfe6f7b73a70b11b16 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_goblet_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.37e-07 | 177 | 126 | 7 | 363e07b0f347f3716d530a28ead854b98e27d37c | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-Proliferating_T_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.91e-07 | 185 | 126 | 7 | 0e0f043ad6d2a62cd47ce39911ad81feab4a4d7e | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.91e-07 | 185 | 126 | 7 | 89b85ce8026dc80c1bd9f76dfe16401c173b7946 | |
| ToppCell | (2)_5-FU-(2)_LEPR+_perivascular_cells_and_VE-Cad+_vascular_cells_(mixed)|(2)_5-FU / Stress and Cell class | 1.07e-06 | 187 | 126 | 7 | 6bbf0f7fe203274dae8d582652f35cd3187c0065 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.14e-06 | 189 | 126 | 7 | e9d5e858e320c6e9913c1ea6a54967d21eda605f | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.27e-06 | 192 | 126 | 7 | f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.27e-06 | 192 | 126 | 7 | ee085e04d5dcfb657522484ed20b8c1ddeccfe0c | |
| ToppCell | ILEUM-inflamed-(7)_Endothelial_cell-(7)_Lymphatics|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.27e-06 | 192 | 126 | 7 | d43caf42ec744e895137f31ef65a990e250669d2 | |
| ToppCell | Control-Lymphoid-Proliferating_CD4_T_cells|Control / Condition, Lineage and Cell class | 1.32e-06 | 193 | 126 | 7 | 33d409d6ed1c606337248587ad997ac5f67f081d | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-06 | 195 | 126 | 7 | 93c345e70d6c8ff5d12fd63d73228c1700b804a0 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 1.67e-06 | 200 | 126 | 7 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Granulocytic-Neutrophil-Neu_c2-CXCR4(low)|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.48e-06 | 144 | 126 | 6 | 3d880c140db4a0e7602bfddcb73a42a68c2848d5 | |
| ToppCell | 10x5'-Lung-Lymphocytic_NK-Cycling_NK|Lung / Manually curated celltypes from each tissue | 9.96e-06 | 173 | 126 | 6 | d815832f89f70662706620e3b03ebb1dabec0034 | |
| ToppCell | droplet-Lung-1m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-proliferating_NK|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.96e-06 | 173 | 126 | 6 | c399786aa25bdbe3394988db6955842b5b7e6b41 | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-Proliferating_NK|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.96e-06 | 173 | 126 | 6 | 31784679190fbd95fc23d7c66008eb21b8c7cc5d | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.06e-05 | 175 | 126 | 6 | 74800a10f5ff25d5414fbccb0668f92ff077d1cc | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.10e-05 | 176 | 126 | 6 | 682a1dfcc507ec540f5fadf08e872533ea9f0291 | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-05 | 179 | 126 | 6 | b88791dd4e73bb8410ca090938a1a45b0bc16e69 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.21e-05 | 179 | 126 | 6 | d1365d48d1b017a7917f4f63a82ac4720c3d87df | |
| ToppCell | ILEUM-non-inflamed-(7)_Lymphatics|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.21e-05 | 179 | 126 | 6 | 99777a8931356d1206b8ab22aaa1b1d5a600b809 | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-05 | 179 | 126 | 6 | c063028b82c68d929aef2421daade9dc189a6963 | |
| ToppCell | PBMC-Mild-Hematopoietic-Platelet-Platelet-plt_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.25e-05 | 180 | 126 | 6 | 1be264962fd4ed0bb59f9b8a6956c4239ca32e05 | |
| ToppCell | PBMC-Mild-Hematopoietic-Platelet-Platelet-plt_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.25e-05 | 180 | 126 | 6 | 5568063c2518fadb638e665635061ec10d00fb6a | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mast-Mast-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.29e-05 | 181 | 126 | 6 | c35ca98c474e31917e0a53c092397e0d8d18b37c | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.29e-05 | 181 | 126 | 6 | e4dbc09f0210de465d8347969b301c22463a2b7d | |
| ToppCell | COVID-19_Mild|World / Disease Group and Platelet Clusters | 1.33e-05 | 182 | 126 | 6 | 90c61e10c7860bfba6ccfe6f37671c8924637f7b | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.33e-05 | 182 | 126 | 6 | 08aff7112c9dac0ef5540300516a604782b21169 | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-Proliferating_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-05 | 183 | 126 | 6 | 769a022fe8568ec49e66f792cc5777e713a7571c | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-05 | 183 | 126 | 6 | aac0695fafa59cabd920ee18b1139d3e00d898e8 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.46e-05 | 185 | 126 | 6 | 9f19f04fc4d97dfc2dd78cde77b515f1cb5d51ec | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.46e-05 | 185 | 126 | 6 | f4ac62009c0ad3346e71b809e17727303c4df153 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.50e-05 | 186 | 126 | 6 | 948815663c212c4311329d503b5991cbbbff9808 | |
| ToppCell | 10x5'-lymph-node_spleen-Hematopoietic_progenitors-Progenitor_pre-Lymphocytic-T|lymph-node_spleen / Manually curated celltypes from each tissue | 1.50e-05 | 186 | 126 | 6 | 17eec1efad1f5e9ced1eb6bc9eb5dd7ded789c61 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-05 | 186 | 126 | 6 | 15ab6666748a641226e42e6ca6eeaf186a501c95 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-05 | 186 | 126 | 6 | 4ed1b97e2552f3c4134f25665d7513498ffac16c | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.55e-05 | 187 | 126 | 6 | 13731298bc562ec29582f5da1b4c97261284f6f1 | |
| ToppCell | B_cells-Plasmablasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.65e-05 | 189 | 126 | 6 | 87cb7b6ba9fd57100d68e6eaeecd1ac6ab22d1c6 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.70e-05 | 190 | 126 | 6 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | mild_COVID-19_(asymptomatic)-Platelet|World / disease group, cell group and cell class (v2) | 1.70e-05 | 190 | 126 | 6 | 7aaf82f0c235363afb95cf1fa51c2a5b070b1af8 | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.75e-05 | 191 | 126 | 6 | 15dbc5a03bfab8931c0fd385b0f25874736ae874 | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibroblast|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-05 | 191 | 126 | 6 | 9214655dca96d766737c9f30b624d7fe7050342e | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-Proliferating_T_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.75e-05 | 191 | 126 | 6 | 45c15f5ce4a207ac944bed65d45f06c1657d1a6d | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 1.80e-05 | 192 | 126 | 6 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-05 | 192 | 126 | 6 | 11088878043a6ff95ba1970361256a82e434b80a | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.80e-05 | 192 | 126 | 6 | 4e47a02007f562f29ba5910df64d32a0167d0bd1 | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-05 | 193 | 126 | 6 | 9c2f58b4c89dc084a1a6e53952ea793e87a96660 | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-05 | 193 | 126 | 6 | db881cc129b45031fd84d052768cef53508de196 | |
| ToppCell | COVID-19_Mild-PLT_4|World / Disease Group and Platelet Clusters | 1.85e-05 | 193 | 126 | 6 | 98a52523aa1efd5d14a2878ed106828a80a33aa2 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.91e-05 | 194 | 126 | 6 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | LA-14._Fibroblast_III|World / Chamber and Cluster_Paper | 1.91e-05 | 194 | 126 | 6 | 803fa83ceada17c38ca9f933b888f7e7b0b90761 | |
| ToppCell | (6)_Endothelial_cells-(6)_Endothelial-F_(Lymphatics)|(6)_Endothelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.91e-05 | 194 | 126 | 6 | 9441202d6fa2ffbef9277d48ae9bc98876c26ec5 | |
| ToppCell | LA-02._Fibroblast_II|LA / Chamber and Cluster_Paper | 1.91e-05 | 194 | 126 | 6 | 234d1494c114cce77c619708bbcd8d5ce805f19b | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Myeloid|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.96e-05 | 195 | 126 | 6 | 027075e9c62b5754a014a9d1393e1b0f5ae42e41 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.96e-05 | 195 | 126 | 6 | f54bc4454270ff06e85596f98199372b50d0179f | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|kidney / Disease (COVID-19 only), tissue and cell type | 1.96e-05 | 195 | 126 | 6 | 7e05e56f8d0a7a052830c7db12b10dace7d10760 | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 1.96e-05 | 195 | 126 | 6 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Myeloid-Megakaryocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.96e-05 | 195 | 126 | 6 | 1bcc0c8b1281396b1433ce5a2ec8681de47ce9ad | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 1.96e-05 | 195 | 126 | 6 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-05 | 195 | 126 | 6 | e9c7eb0b1a2d58f69b4e839665101948bd4527b8 | |
| ToppCell | facs-Thymus-Thymus_Epithelium|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-05 | 196 | 126 | 6 | 6bc1187dfc4860a4e09032d7ea87ba3d9fe9f363 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-05 | 196 | 126 | 6 | c8c89e469402e11aa2a9561e859b6fd1fb66c39b | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-05 | 196 | 126 | 6 | 2029f58ce6a7b8c35d3a7496c3341391990909ce | |
| ToppCell | facs-Lung-nan|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-05 | 196 | 126 | 6 | b05f77f3990b662682ffeaf0e4c2fb190e0a6e65 | |
| ToppCell | facs-Lung-nan-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-05 | 196 | 126 | 6 | 787c6cd92035e0b1108c2c086c42a229016e476b | |
| ToppCell | Lung_Parenchyma-Control-Lymphocyte-B-Plasmablast-Plasmablast-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.08e-05 | 197 | 126 | 6 | 0d38d126b1e653398426255e95449f1150eac1b0 | |
| ToppCell | Mild_COVID-19-T/NK-proliferating_T/NK|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 2.08e-05 | 197 | 126 | 6 | 5fd52fba2cb6fa67377f873da2ff6ce9c83b0591 | |
| ToppCell | Parenchyma_Control_(B.)-Immune-TX-Plasma_cells|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 2.08e-05 | 197 | 126 | 6 | 7ffb373d5b72c67e4816f14ea9a7a2024dc7a93a | |
| ToppCell | tumor_Lung-Endothelial_cells-Lymphatic_ECs|Endothelial_cells / Location, Cell class and cell subclass | 2.08e-05 | 197 | 126 | 6 | a05237ee6d31d9eab491dd7007859d6285cf1424 | |
| ToppCell | Lung_Parenchyma-Control-Lymphocyte-B-Plasmablast|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.08e-05 | 197 | 126 | 6 | 2e76e9ebd8702bfeefd396cbf5114eee0f24c19b | |
| ToppCell | Lung_Parenchyma-Control-Lymphocyte-B-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.08e-05 | 197 | 126 | 6 | 207fce47e547fafbaf64a22efe3488e74bf19bed | |
| ToppCell | normal_Lung-Endothelial_cells-Lymphatic_ECs|Endothelial_cells / Location, Cell class and cell subclass | 2.08e-05 | 197 | 126 | 6 | c838d0f64e3b43a616a9e381b8139bfe9aa32da7 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.08e-05 | 197 | 126 | 6 | 434a5686a103bb766e0d80038413f0e12ea3981a | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.08e-05 | 197 | 126 | 6 | 6bddfa199ca812d9e518eaa02c3d4fb67e9f5b16 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.08e-05 | 197 | 126 | 6 | c0a71a9452febda433bc544e4ac0a79c43dcf13e | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.08e-05 | 197 | 126 | 6 | c747c496ac090309b7f8a3e9d840928f12c83f2f | |
| ToppCell | Caecum-B_cell-B_cell_cycling|Caecum / Region, Cell class and subclass | 2.14e-05 | 198 | 126 | 6 | 61294fe99a5641ad359796022c3d038470076b3c | |
| ToppCell | COVID-19_Severe-PLT_4|COVID-19_Severe / Disease Group and Platelet Clusters | 2.14e-05 | 198 | 126 | 6 | abfddbee99ef8c7719e6e6f62571e9be030e4acf | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.14e-05 | 198 | 126 | 6 | 285f729140b1df029c24f6ca1d2438470ac51794 | |
| ToppCell | COVID-19_Mild-PLT_4|COVID-19_Mild / Disease Group and Platelet Clusters | 2.14e-05 | 198 | 126 | 6 | 3d8c33dba759df0974aeb2b9a6b5167ae7a18e1f | |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal-fibroblast|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.14e-05 | 198 | 126 | 6 | 0dc7d59a07428a7b7e8bdc81f0e2417dd4ce3cf2 | |
| ToppCell | Fibroblasts-HLA-DRA_high_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 2.14e-05 | 198 | 126 | 6 | e8c0fbf306fae13e97caa294d7c99a564bd97130 | |
| ToppCell | Caecum-(2)_B_cell-(24)_B_cell_cycling|Caecum / shred on region, Cell_type, and subtype | 2.14e-05 | 198 | 126 | 6 | 568d47770cd20c6569ca84ea1eafde367642d68b | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.20e-05 | 199 | 126 | 6 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Macroglial-Astrocyte|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 2.26e-05 | 200 | 126 | 6 | 158ba898312c73bcb54c675a4860874a1dd58662 | |
| ToppCell | NS-control-d_0-4-Epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.26e-05 | 200 | 126 | 6 | d014959891893b6d3854a471fba1dc50c6625a0a | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-squamous_epithelial_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.26e-05 | 200 | 126 | 6 | 1c02a7f4047d1d2208cc522c6bb4a4989d7845bb | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.26e-05 | 200 | 126 | 6 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | mild-T/NK_proliferative|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.26e-05 | 200 | 126 | 6 | 25b4a1a33348e274bd4457efc0d6faa5421c3d31 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 2.26e-05 | 200 | 126 | 6 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| Computational | Genes in the cancer module 89. | 1.32e-06 | 14 | 67 | 4 | MODULE_89 | |
| Computational | Genes in the cancer module 203. | 2.37e-06 | 16 | 67 | 4 | MODULE_203 | |
| Computational | Genes in the cancer module 90. | 3.09e-06 | 17 | 67 | 4 | MODULE_90 | |
| Computational | Chromatin and nucleosomes. | 3.95e-06 | 18 | 67 | 4 | MODULE_552 | |
| Computational | Genes in the cancer module 534. | 3.95e-06 | 18 | 67 | 4 | MODULE_534 | |
| Computational | Genes in the cancer module 222. | 9.27e-06 | 22 | 67 | 4 | MODULE_222 | |
| Computational | Genes in the cancer module 168. | 9.27e-06 | 22 | 67 | 4 | MODULE_168 | |
| Computational | Genes in the cancer module 189. | 1.12e-05 | 23 | 67 | 4 | MODULE_189 | |
| Computational | Genes in the cancer module 127. | 1.86e-05 | 26 | 67 | 4 | MODULE_127 | |
| Computational | Chromatin. | 2.52e-05 | 28 | 67 | 4 | MODULE_421 | |
| Drug | Methylmethacrylate | 5.38e-13 | 39 | 123 | 9 | ctd:D020366 | |
| Drug | Telenzepine dihydrochloride [147416-96-4]; Up 200; 9uM; MCF7; HT_HG-U133A | H2BC11 SEMA4D DYNC2H1 INTS1 APBB2 PPP2R3A H2BC14 H2BC5 CHPF2 | 1.27e-06 | 197 | 123 | 9 | 7419_UP |
| Drug | Berberine | 1.57e-06 | 202 | 123 | 9 | ctd:D001599 | |
| Disease | Inguinal hernia | 1.83e-06 | 287 | 114 | 9 | HP_0000023 | |
| Disease | central corneal thickness | 2.78e-05 | 309 | 114 | 8 | EFO_0005213 | |
| Disease | corneal resistance factor | 6.61e-05 | 451 | 114 | 9 | EFO_0010067 | |
| Disease | interleukin 5 receptor subunit alpha measurement | 1.47e-04 | 5 | 114 | 2 | EFO_0008186 | |
| Disease | intraocular pressure measurement | PCSK5 COL6A3 DYNC2H1 ISOC1 GLCCI1 PNPT1 PPP2R3A ABCA6 ADAMTS17 | 1.65e-04 | 509 | 114 | 9 | EFO_0004695 |
| Disease | VACTERL association (implicated_via_orthology) | 2.20e-04 | 6 | 114 | 2 | DOID:14679 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | RCE1 NET1 DYNC2H1 FRMPD1 OCA2 ZC3H11A FCRL3 H2BC4 MKI67 KAT6B H2BC12 RAD54L DOP1A | 2.65e-04 | 1074 | 114 | 13 | C0006142 |
| Disease | Sacral agenesis | 3.07e-04 | 7 | 114 | 2 | C0344490 | |
| Disease | femoral hernia | 3.07e-04 | 7 | 114 | 2 | EFO_1001791 | |
| Disease | Saldino-Noonan Syndrome | 1.31e-03 | 14 | 114 | 2 | C0036069 | |
| Disease | smoking behavior, BMI-adjusted waist circumference | 1.31e-03 | 122 | 114 | 4 | EFO_0004318, EFO_0007789 | |
| Disease | response to calcium channel blocker | 1.34e-03 | 56 | 114 | 3 | EFO_0007767 | |
| Disease | amyloid-beta measurement, Alzheimer's disease biomarker measurement | 1.71e-03 | 16 | 114 | 2 | EFO_0005194, EFO_0006514 | |
| Disease | lifestyle measurement | 2.23e-03 | 235 | 114 | 5 | EFO_0010724 | |
| Disease | maximal midexpiratory flow rate | 2.69e-03 | 20 | 114 | 2 | EFO_0004313 | |
| Disease | in situ carcinoma (is_marker_for) | 2.96e-03 | 21 | 114 | 2 | DOID:8719 (is_marker_for) | |
| Disease | respiratory symptom measurement, COVID-19 | 2.98e-03 | 74 | 114 | 3 | EFO_0007939, MONDO_0100096 | |
| Disease | body surface area | 3.55e-03 | 643 | 114 | 8 | EFO_0022196 | |
| Disease | partial thromboplastin time | 3.86e-03 | 24 | 114 | 2 | EFO_0004310 | |
| Disease | Sjogren's syndrome (is_marker_for) | 3.86e-03 | 24 | 114 | 2 | DOID:12894 (is_marker_for) | |
| Disease | Noonan Syndrome | 3.86e-03 | 24 | 114 | 2 | C0028326 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TLTRRSISQQKSGVS | 976 | Q9UKV3 | |
| AVRVGRAVATTAVIS | 36 | Q86TW2 | |
| EVNVTSRVALAVSSR | 136 | P59826 | |
| ADSVTRRVTTNVKRG | 726 | Q92870 | |
| TIIERSSARSSIAEV | 236 | P54284 | |
| RTTSEATVISVRKTS | 1086 | Q8IZF6 | |
| ELAKRVSRLSTSTTI | 641 | Q9UEY8 | |
| SRTVRAELSFSVSQV | 21 | P0C5Y9 | |
| SRTVRAELSFSVSQV | 21 | P0C5Z0 | |
| QTERIRTATALTTSI | 1256 | Q8N139 | |
| VSILQTRKTTVAATT | 206 | Q9UKB5 | |
| VSLAVSRLSRIVSSA | 226 | O95782 | |
| VVTQGTATRSRKTAQ | 656 | Q5JWR5 | |
| AKSQQVRTSSTIRRT | 156 | Q86VQ1 | |
| KATRSNVRVTVTATA | 571 | Q9NQ90 | |
| ARTSGTAVSRLQVKA | 296 | A6H8M9 | |
| KRSTITSREIQTAVR | 86 | P57053 | |
| RRTIVSCTRIVNKTT | 821 | Q8TE56 | |
| SFSNSTRTREVVKVI | 481 | Q96MI9 | |
| VTRSTSRAVTVAARP | 361 | Q76M96 | |
| VSLAVSRLSRIVTSA | 226 | O94973 | |
| TFEVLTRETVSISIR | 291 | Q04671 | |
| RIVSSIRAISSTQGK | 221 | Q8NGA2 | |
| AVTRSRSSDKVVLVS | 506 | Q92698 | |
| KRSTITSREIQTAVR | 86 | Q16778 | |
| KRSTITSREIQTAVR | 86 | Q5QNW6 | |
| KRSTITSREIQTAVR | 86 | P06899 | |
| KRSTITSREIQTAVR | 86 | Q99877 | |
| KRRRINSSVTTETIS | 1136 | Q8WYB5 | |
| TRRTLTGTAALTVQS | 31 | P09960 | |
| QIVSTLTRASVARIF | 196 | Q7L1V2 | |
| KLTAQRRASTVSSVT | 531 | Q7Z628 | |
| NTAIRTSIARVSATD | 161 | Q14517 | |
| TEVSRTEVISSRGTS | 8446 | Q8WXI7 | |
| LTSSAVTSVAKVVRV | 6 | P40305 | |
| VTSVAKVVRVASGSA | 11 | P40305 | |
| RLARTGIIVTTSEAV | 251 | Q96CN7 | |
| TGSFSRVVRVEQKTT | 71 | Q96QS6 | |
| AIRAGKQRTISSATV | 611 | Q9UJA3 | |
| KRSTITSREIQTAVR | 86 | Q99879 | |
| VVSSTVRAVIATLRS | 1516 | Q8N201 | |
| IAASAVRAKATRISI | 156 | P33992 | |
| KASDISVLVTSRVRS | 356 | A4FU01 | |
| ITIRSISAAGRSQAS | 91 | Q5VTL7 | |
| RGASVIIRFVTNTTK | 36 | Q9H0R4 | |
| TTLVSRIGSVTISDV | 276 | Q9BVA6 | |
| RVTTKVSITRLETAS | 461 | Q14118 | |
| KRSTITSREIQTAVR | 86 | P58876 | |
| KRSTITSREIQTAVR | 86 | Q93079 | |
| KRSTITSREIQTAVR | 86 | O60814 | |
| AVIKRRFTSVLVVSS | 66 | Q9Y256 | |
| HSRTIKRSVISSRGT | 76 | Q92824 | |
| ALQSSVVATSKERTR | 111 | Q9H307 | |
| SVVRSGTTRLSVGVT | 2216 | Q7Z5P9 | |
| ILTEATSSTGRIRAT | 6351 | Q7Z5P9 | |
| SRITRAEVITEATTF | 7161 | Q7Z5P9 | |
| VVSSFAVSGTVRRLQ | 181 | Q13608 | |
| RVDVTSLGRTTVTLA | 181 | Q8TB73 | |
| SRTTNVASVFPTRIT | 276 | Q9HCC8 | |
| ASTLESKSVQRVTRS | 3211 | P46013 | |
| SRSGTSTVRIVVLDV | 221 | Q9UN67 | |
| VTAVDVSTNRSVRAS | 666 | Q96MM6 | |
| SSSRIIERIFSGAVT | 931 | Q06190 | |
| AKVVAIVSRRSRSTS | 1436 | Q86UR5 | |
| SSSAARAVAVVSVLV | 211 | Q16322 | |
| LNERRTTTTTLTVDV | 241 | Q96QU1 | |
| IVTEVNFTTTRSGLR | 3386 | Q8NCM8 | |
| SKRSTISSREIQTAV | 86 | Q96A08 | |
| KRSTITSREIQTAVR | 86 | P33778 | |
| KRSTITSREIQTAVR | 86 | P62807 | |
| VQGTVTIRNISALSS | 196 | Q5DX21 | |
| KRSTITSREVQTAVR | 86 | Q8N257 | |
| IRQRQVTTGSETSTK | 2251 | Q4AC94 | |
| TLRRLSITSVTSSVV | 1666 | Q9H7D0 | |
| ALRARTVTFGVITSI | 141 | P51677 | |
| ALRARTVTFGVITSI | 141 | P32246 | |
| KSVIDSRVSSISAIR | 931 | Q5SYB0 | |
| KVRLEGRSTTSLSVS | 441 | P29317 | |
| SKISTISSVRNLTIR | 2591 | P15924 | |
| KRSTITSREIQTAVR | 86 | Q99880 | |
| KRSTITSREIQTAVR | 86 | P23527 | |
| TSVIVTGVQVSSRIF | 136 | B0YJ81 | |
| VSRFAQVIRSSGIVS | 1556 | P12111 | |
| TASVSATAAPRTVRV | 376 | Q15723 | |
| RRTQSSLTVSEVLTR | 991 | Q86V48 | |
| KVVTLNVTGTSRNRT | 556 | Q96P31 | |
| SGRTTLTSREVQTAV | 81 | A0A2R8Y619 | |
| VSRSVPLVTSVRNTT | 321 | Q6BAA4 | |
| RTTLVDSRTSVTDVK | 106 | Q96EE3 | |
| RGSTRDTIVIAVSST | 646 | Q16820 | |
| VVGETTSRTITLTNV | 631 | Q9C0B2 | |
| TTFVSLVVSGRVVAA | 176 | Q9BT04 | |
| GRVSRSSSAKVTINV | 681 | Q9BZA8 | |
| SRSGTSTIRIVVLDV | 221 | Q9Y5E1 | |
| VVLSSSVQRTAGKTA | 696 | O00268 | |
| RTFLQTVSSEKVRST | 31 | Q96EL3 | |
| VRTVASATTAIEIRR | 256 | Q96D71 | |
| AVSNVRSVASRTLVR | 1501 | A6NHR9 | |
| SVLIVTVGLAATTRT | 36 | Q8WV15 | |
| TLVATSVNSVTGIRI | 66 | Q86YL7 | |
| RTTTTVGATTTQFRV | 391 | Q6UX71 | |
| VGATTTQFRVLTTTR | 396 | Q6UX71 | |
| TQFRVLTTTRRAVTS | 401 | Q6UX71 | |
| FEIGSTTTTLTIRRA | 196 | A0A087WV53 | |
| CSRALSVVSTVVRAS | 1906 | O75592 | |
| SRIATKVLVASTQGS | 666 | Q92854 | |
| AVETSRRVAASRTKA | 276 | A6NJG2 | |
| ATTVVRTLNDRSSIV | 756 | Q8TCS8 | |
| TVVSETISSKNIISR | 536 | Q68D10 | |
| IRLTSVGVSVFTLTI | 126 | P32247 | |
| RVTQSSIRTPVVSIS | 121 | Q8N4F0 | |
| SSESETSVRRKVSLV | 326 | Q9P2M7 | |
| VLTSRATLSTLAVAV | 106 | Q9P2E5 | |
| TALSTVSSGVQRVLV | 471 | O75122 | |
| LVSGTSSALRTITRV | 346 | Q53QW1 | |
| VSSINTISRAKIRTV | 266 | P47901 | |
| RRTVSESVIAVKASF | 216 | Q8IXZ2 | |
| GKTESSSVVRTRSNR | 1496 | Q8WWQ0 | |
| SRRTVRVVASKQGST | 96 | Q71H61 | |
| RSSSTIRIKTFSEVL | 396 | O75152 | |
| AIGSASVVTVLRVRS | 321 | Q9Y639 | |
| ISSSATRVIVKTAGN | 26 | Q8IYU4 | |
| LSVFQVITVSSRKSR | 101 | Q7Z5H5 | |
| RSSSTIRIKTFSEVL | 396 | A0A1B0GTU1 | |
| VLITARVTTERTAGT | 126 | Q86XT9 | |
| VVASSVTGVVDLARR | 121 | Q00G26 | |
| MASVVLALRTRTAVT | 1 | Q9P0M9 | |
| VVRSRIQTSLTSASL | 986 | P49815 | |
| RSVVSETAATCSVLR | 166 | Q5SQQ9 | |
| GRVLASRNTKTSVVV | 616 | P54296 | |
| TTAGTVSSTTEVRER | 651 | O14974 | |
| TAGVSSSLDRATRTI | 906 | Q14957 |